What is Direava's new AI called and what is its main function?

The new AI is called 'Surgical VLM' (Surgical Vision-Language Model). Its main function is to understand surgical situations in real-time and engage in advanced dialogue with surgeons, acting like a 'surgeon's brain' to infer next steps and potential risks.

How is Surgical VLM different from previous generative AI in surgery?

Previous surgical AI primarily focused on 'anatomical recognition' (identifying organs and structures like eyes). Surgical VLM adds 'advanced situation understanding' (a 'brain function') that interprets the context of the surgery to provide guidance and engage in dialogue, going beyond simple image recognition.

Where and when was the demonstration of Surgical VLM conducted?

The demonstration was conducted during a gastric cancer surgery at Keio University Hospital on February 20, 2026.

What are the future plans for Surgical VLM?

Direava plans to launch the service commercially within 2026. They also intend to conduct further demonstrations for surgeries other than gastric cancer to support surgeon training and advanced surgical education.

What is the GENIAC project?

GENIAC (Generative AI Accelerator Challenge) is a project led by NEDO and the Ministry of Economy, Trade and Industry aimed at accelerating R&D and support for generative AI, including the development of domain-specific foundation models.

AI News NQ Analysis

Developed a Surgeon-Specific Generative AI that Brings a "Brain" to the Operating Room – Successful Demonstration in Surgical Field, Full-Scale Business Launch Underway –

NQ Score 50/100

AI Summary (NQ-processed)

Direava has developed and successfully demonstrated a surgeon-specific generative AI that understands and interacts with surgical situations in real-time.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is Direava's new AI called and what is its main function?: A: The new AI is called 'Surgical VLM' (Surgical Vision-Language Model). Its main function is to understand surgical situations in real-time and engage in advanced dialogue with surgeons, acting like a 'surgeon's brain' to infer next steps and potential risks.
Q: How is Surgical VLM different from previous generative AI in surgery?: A: Previous surgical AI primarily focused on 'anatomical recognition' (identifying organs and structures like eyes). Surgical VLM adds 'advanced situation understanding' (a 'brain function') that interprets the context of the surgery to provide guidance and engage in dialogue, going beyond simple image recognition.
Q: Where and when was the demonstration of Surgical VLM conducted?: A: The demonstration was conducted during a gastric cancer surgery at Keio University Hospital on February 20, 2026.
Q: What are the future plans for Surgical VLM?: A: Direava plans to launch the service commercially within 2026. They also intend to conduct further demonstrations for surgeries other than gastric cancer to support surgeon training and advanced surgical education.
Q: What is the GENIAC project?: A: GENIAC (Generative AI Accelerator Challenge) is a project led by NEDO and the Ministry of Economy, Trade and Industry aimed at accelerating R&D and support for generative AI, including the development of domain-specific foundation models.